Joyce Qian is a Senior Scientist in the Real-World Evidence team. She is proficient in advanced study designs including causal inference methods and has extensive experience working with large administrative claims, electronic medical records (EMR), clinical trial data, and cohort data.
Joyce has over ten years of experience in conducting retrospective and prospective cohort studies, multi-site medical chart reviews, surveillance studies, ecological studies, prediction studies, health service research, cost analysis, and meta-analysis. She has therapeutic experience in the following areas: infectious diseases, mental health, heart diseases, and kidney diseases.
Prior to joining OPEN Health, Joyce led surveillance studies on blood products across the FDA Biologics Effectiveness and Safety (BEST) network with the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM). She has previously worked at the Medical Technology and Practice Patterns Institute, the Virginia Department of Health, and the San Francisco Veterans Affairs Medical Center, where she provided study design and analytical support for internal and external stakeholders. Joyce earned her PhD in Epidemiology from Johns Hopkins University and MPH from Virginia Commonwealth University. She is a member of International Society for Pharmacoepidemiology and has authored and co-authored 16 peer-reviewed publications.